Symbol="IMVT"
AssetType="Common Stock"
Name="ImmunovantÂ Inc"
Description="Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. The company is headquartered in New York, New York."
CIK="1764013"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="REAL ESTATE & CONSTRUCTION"
Industry="BLANK CHECKS"
Address="412 W. 15TH STREET, FLOOR 9, NEW YORK, NY, US"
FiscalYearEnd="March"
LatestQuarter="2023-03-31"
MarketCapitalization="2421944000"
EBITDA="-208083008"
PERatio="None"
PEGRatio="None"
BookValue="2.781"
DividendPerShare="0"
DividendYield="0"
EPS="-1.74"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.282"
ReturnOnEquityTTM="-0.507"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="28.23"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.727"
EVToRevenue="-"
EVToEBITDA="-8.22"
Beta="0.931"
num_52WeekHigh="24.18"
num_52WeekLow="3.9"
num_50DayMovingAverage="19.79"
num_200DayMovingAverage="15.73"
SharesOutstanding="130563000"
DividendDate="None"
ExDividendDate="None"
symbol="IMVT"
open="19.05"
high="19.31"
low="18.16"
price="18.55"
volume="733803.00"
latest_trading_day="2023-07-07"
previous_close="19.09"
change="-0.54"
change_percent="-2.8287%"
aroon_positive_momentum_days="63"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="63"
Volume_recent_avg="974023"
Change_recent_avg="-0.03"
Delta_recent_avg="0.83"
Variance_recent_avg="0.41"
Change_ratio_recent_avg="-0.22"
RSI_change="FALSE"
ADX_change="FALSE"

event="aroon_milestone_positive_45"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="63"
Aroon_momentum_negative="37"
image_negative_thumbnail_id_1="173"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0003.jpeg"
image_negative_thumbnail_id_2="1145"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0178.jpeg"
image_neutral_thumbnail_id_1="547"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_neutral_thumbnail_id_2="545"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_positive_thumbnail_id_1="992"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_positive_thumbnail_id_2="686"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0022.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1178"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0012.jpeg"
